Statistics
Publications
21
Citations
3.5K
H-Index
19
Active since
1995
Debra T. Chao is an author at AbbVie (United States) specializing in oncology, cancer immunotherapy, and immunology.
Publications per year
1995–2021
21
21
BID: a novel BH3 domain-only death agonist.
Kai Wang, Xiaoming Yin, Debra T. Chao et al. · Genes & Development · 1996 · 962 citations · Full text
Bcl-XL and Bcl-2 repress a common pathway of cell death.
Debra T. Chao, Gerald P. Linette, Lawrence Boise et al. · The Journal of Experimental Medicine · 1995 · 398 citations · Full text
1–5 of 21